Longitudinal Outpatient Treatment for Cannabis Use Disorder
Part of paid clinical trials in Boulder, Colorado.
- Sponsor
- University of Colorado, Boulder
- Study ID
- NCT06107062
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Cannabis Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cannabidiol - fsCBD — DRUGFull-spectrum (i.e., fsCBD, 7.8mg THC (3.4mg BID)), plant-derived CBD capsules produced by Ecofibre/Ananda Hemp will be used.
- Placebo — DRUGPlacebo arm
- Cannabidiol - bsCBD — DRUGBroad-spectrum (i.e., bsCBD, 0% THC), plant-derived CBD capsules produced by Ecofibre/Ananda Hemp will be used
Study Details
This study is a placebo-controlled randomized trial comparing the effects of hemp-derived cannabidiol (CBD) with and without Delta-9-tetrahydrocannabinol (THC), relative to placebo, on reducing cannabis use and cannabis use disorder (CUD) symptoms in adult treatment seeking cannabis concentrate users with CUD. Participants enroll in the study for 8 weeks (with telehealth follow-ups at 12 and 16 weeks) and are randomized to either full spectrum CBD, broad spectrum CBD, or placebo. Participants are also engaged in five weeks of psychotherapy treatment for CUD. Blood is collected to quantify investigational drug exposure and cannabis use. Participants also complete self-report measures of medical history, sleep quality, subjective cognitive function, physical activity, psychological functioning, substance use, and acute drug effects.
Key Dates
- Start date
- May 16, 2024
- Status verified
- Jun 2025
- Primary completion
- Mar 31, 2028
- Completion
- Mar 31, 2029
Study Design
- Enrollment
- 165 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 400mg Full Spectrum Cannabidiol (fsCBD)
- Experimental: 400mg Broad Spectrum Cannabidiol (bsCBD)
- Placebo Comparator: Placebo
Primary Outcome Measure
Difference in cannabis use [ Time Frame: 8 weeks ]
Central Contacts
- Jonathan Lisano, PhD303-492-9549
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Boulder | Boulder | Colorado | 80301 | Devon Rapken |
Find similar trials in Boulder, CO
Related Studies
- Effects of THC on Alcohol Consumption and Neural Correlates of RewardPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- A Study of Cannabidiol in Young Adult Cannabis UsersPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Cannabidiol and Cannabis Concentrate UsersPHASE2 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- SV2 PET Imaging With [11C]APP311Recruiting · Yale University · New Haven, Connecticut